19988 Federal Register / Vol. 80, No. 71 / Tuesday, April 14, 2015 / Notices 

1The agencies that were party to the rulemaking 

were the Office of the Comptroller of the Currency 

(OCC); Board of Governors of the Federal Reserve 

System (Board); and Federal Deposit Insurance 

Corporation (FDIC). 

2For purposes of this guidance, the term 

‘‘banking organization’’ means national banks and 

Federal branches and agencies supervised by the 

OCC; state member banks, bank holding companies, 

and all other institutions for which the Federal 

Reserve is the primary federal supervisor; and state 

nonmember insured banks and other institutions 

supervised by the FDIC. 

3. Report title: Recordkeeping and 

Disclosure Provisions associated with 

Stress Testing Guidance. 

Agency form number: FR 4202. 

OMB control number: 7100–0348. 

Frequency: On-occasion. 

Reporters: State member banks, bank 

holding companies, and all other 

institutions for which the Federal 

Reserve is the primary federal 

supervisor. 

Estimated annual reporting hours: 

Recordkeeping, 18,000 hours; 

Disclosure, 8,000 hours. 

Estimated average hours per response: 

Recordkeeping, 180 hours; Disclosure, 

80 hours. 

Number of respondents: 

Recordkeeping, 100; Disclosure, 100. 

General description of report: This 

information collection is voluntary and 

is authorized pursuant to sections 11(a), 

11(i), 25, and 25A of the Federal Reserve 

Act (12 U.S.C. 248(a), 248(i), 602, and 

611), section 5 of the Bank Holding 

Company Act (12 U.S.C. 1844), and 

section 7(c) of the International Banking 

Act (12 U.S.C. 3105(c)). To the extent 

the Federal Reserve collects information 

during an examination of a banking 

organization, confidential treatment 

may be afforded to the records under 

exemptions 4 and 8 of the Freedom of 

Information Act (FOIA) (5 U.S.C. 

552(b)(4) and (8)). 

Abstract: The interagency guidance 

outlines high-level principles for stress 

testing practices, applicable to all 

Federal Reserve-supervised, FDICsupervised, and OCC-supervised 

banking organizations 1 with more than 

$10 billion in total consolidated assets. 

In developing a stress testing framework 

and in carrying out stress tests, banking 

organizations 2 should understand and 

clearly document all assumptions, 

uncertainties, and limitations, and 

provide that information to users of the 

stress testing results. To ensure proper 

governance over the stress testing 

framework, banking organizations 

should develop and maintain written 

policies and procedures. 

Board of Governors of the Federal Reserve 

System, April 8, 2015. 

Robert deV. Frierson, 

Secretary of the Board. 

[FR Doc. 2015–08406 Filed 4–13–15; 8:45 am] 

BILLING CODE 6210–01–P 

FEDERAL RETIREMENT THRIFT 

INVESTMENT BOARD 

Sunshine Act; Notice of Meeting 

TIME AND DATE: Parts open to the public 

begin at 8:30 a.m. April 20, 2015. 

PLACE: 10th Floor Board Meeting Room, 

77 K Street NE., Washington, DC 20002. 

STATUS: Parts will be open to the public 

and parts closed to the public. 

MATTERS TO BE CONSIDERED: 

Parts Open to the Public 

1. Approval of the Minutes of the March 

23, 2015 Board Member Meeting. 

2. ED Comments 

3. Monthly Reports 

a. Monthly Participant Activity Report 

b. Legislative Report 

4. Quarterly Metrics Report 

a. Investment Policy 

b. Vendor Financials 

c. Audit Status 

d. Budget Review 

e. Project Activity Report 

5. Annual Financial Audit—CLA 

6. Mainframe Audit 

7. DOL Presentation 

Part Closed to the Public 

8. Security 

CONTACT PERSON FOR MORE INFORMATION: 

Kimberly Weaver, Director, Office of 

External Affairs, (202) 942–1640. 

Dated: April 10, 2015. 

Megan Grumbine, 

Deputy General Counsel, Federal Retirement 

Thrift Investment Board. 

[FR Doc. 2015–08675 Filed 4–10–15; 4:15 pm] 

BILLING CODE 6760–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Initial Review 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces a meeting for the initial 

review of applications in response to 

Funding Opportunity Announcements 

(FOA) GH15–002, Conducting Public 

Health Research in Georgia; FOA GH15– 

003, Conducting Public Health Research 

Activities in Uzbekistan; FOA GH15– 

006, Institutional Research 

Collaboration between the Liverpool 

School of Tropical Medicine and the 

Centers for Disease Control and 

Prevention; FOA GH15–007, Emerging 

Infectious Disease Detection in the 

Veterinary Public Health Sector in 

India; and FOA GH15–008, Conducting 

Operational Research to Identify 

Numbers and Rates, Determine Needs, 

and Integrate Services to Mitigate 

Morbidity and Mortality Among 

Internally Displaced Persons Affected 

by Emergencies. 

TIME AND DATE: 

8:30 a.m.–1:30 p.m., EDT, May 6, 2015 

(Closed) 

PLACE: Teleconference 

STATUS: The meeting will be closed to 

the public in accordance with 

provisions set forth in section 552b(c) 

(4) and (6), title 5 U.S.C., and the 

Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Public Law 92– 

463. 

MATTERS FOR DISCUSSION: The meeting 

will include the initial review, 

discussion, and evaluation of 

applications received in response to 

‘‘Conducting Public Health Research in 

Georgia, FOA GH15–002; Conducting 

Public Health Research Activities in 

Uzbekistan, FOA GH15–003; 

Institutional Research Collaboration 

between the Liverpool School of 

Tropical Medicine and the Centers for 

Disease Control and Prevention, FOA 

GH15–006; Emerging Infectious Disease 

Detection in the Veterinary Public 

Health Sector in India, FOA GH15–007; 

and Conducting Operational Research to 

Identify Numbers and Rates, Determine 

Needs, and Integrate Services to 

Mitigate Morbidity and Mortality 

Among Internally Displaced Persons 

Affected by Emergencies, FOA GH15– 

008.’’ 

CONTACT PERSON FOR MORE INFORMATION: 

Hylan Shoob, Scientific Review Officer, 

Center for Global Health (CGH) Science 

Office, CGH, CDC, 1600 Clifton Road 

NE., Mailstop D–69, Atlanta, Georgia 

30033, Telephone: (404) 639–4796. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 


asabaliauskas on DSK5VPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 71 / Tuesday, April 14, 2015 / Notices 19989 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Claudette Grant, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2015–08521 Filed 4–13–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, Office 

of Infectious Diseases, BSC, OID 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), 

announces the following meeting of the 

aforementioned committee: 

Time and Date: 8:00 a.m.–5:00 p.m., 

EDT, May 6, 2015. 

Place: CDC, Global Communications 

Center, 1600 Clifton Road NE., Building 

19, Auditorium B3, Atlanta, Georgia 

30333. 

Status: The meeting is open to the 

public, limited only by the space 

available. 

Purpose: The BSC, OID, provides 

advice and guidance to the Secretary, 

Department of Health and Human 

Services; the Director, CDC; the 

Director, OID; and the Directors of the 

National Center for Immunization and 

Respiratory Diseases, the National 

Center for Emerging and Zoonotic 

Infectious Diseases, and the National 

Center for HIV/AIDS, Viral Hepatitis, 

STD, and TB Prevention, CDC, in the 

following areas: Strategies, goals, and 

priorities for programs; research within 

the national centers; and overall 

strategic direction and focus of OID and 

the national centers. 

Matters for Discussion: The meeting 

will include a report from the Food 

Safety Modernization Act Surveillance 

Working Group of the BSC, OID; brief 

updates on priority issues for CDC’s 

infectious disease programs; and 

updates and discussions on CDC’s 

Surveillance Strategy and the Global 

Health Security Agenda. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Robin Moseley, M.A.T., Designated 

Federal Officer, OID, CDC, 1600 Clifton 

Road NE., Mailstop D10, Atlanta, 

Georgia 30333, Telephone: (404) 639– 

4461. 

The Director, Management Analysis 

and Services Office has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Claudette Grant, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2015–08518 Filed 4–13–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP); Initial Review 

The meeting announced below 

concerns Comparison and Validation of 

Screening Tools for Substance Use 

Among Pregnant Women, DP15–003, 

initial review. 

SUMMARY: This document corrects a 

notice that was published in the Federal 

Register on March 12, 2015 Volume 80, 

Number 48, page 13011. The times and 

dates should read as follows: 

Times and Dates: 9:00 a.m.–6:00 p.m., 

April 7–8, 2015 (Closed). 

FOR FURTHER INFORMATION CONTACT: M. 

Chris Langub, Ph.D., Scientific Review 

Officer, CDC, 4770 Buford Highway NE., 

Mailstop F46, Atlanta, Georgia 30341, 

Telephone: (770)488–3585, EEO6@

cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Claudette Grant, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2015–08519 Filed 4–13–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES (HHS) 

Centers for Disease Control and 

Prevention 

Healthcare Infection Control Practices 

Advisory Committee (HICPAC) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) announce 

the following meeting for the 

aforementioned committee: 

Time and Date: 2:00 p.m.–3:00 p.m., 

EST, May 11, 2015. 

Place: This meeting will be accessible 

by teleconference. Toll-free +1 (888) 

790–1864, Participant Code: 5920580. 

Status: Open to the public limited 

only by the availability of telephone 

ports. 

Purpose: The Committee is charged 

with providing advice and guidance to 

the Director, Division of Healthcare 

Quality Promotion, the Director, 

National Center for Emerging and 

Zoonotic Infectious Diseases (NCEZID), 

the Director, CDC, the Secretary, Health 

and Human Services regarding (1) the 

practice of healthcare infection 

prevention and control; (2) strategies for 

surveillance, prevention, and control of 

infections, antimicrobial resistance, and 

related events in settings where 

healthcare is provided; and (3) periodic 

updating of CDC guidelines and other 

policy statements regarding prevention 

of healthcare-associated infections and 

healthcare-related conditions. 

Matters for Discussion: The agenda 

will include a follow up discussion on 

the Draft Guideline for the Prevention of 

Surgical Site Infections. Call materials 

will be made available to the public no 

later than 2 business days before the 

call. If CDC is unable to post the 

background material on the HICPAC site 

prior to the meeting, the background 

material will be posted on HICPAC’s 

Web site after the meeting. Background 

material is available at http://

www.cdc.gov/hicpac. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Erin Stone, M.S., HICPAC, Division of 

Healthcare Quality Promotion, NCEZID, 

CDC, 1600 Clifton Road NE., Mailstop 

A–31, Atlanta, Georgia 30333; Email: 

HICPAC@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 


asabaliauskas on DSK5VPTVN1PROD with NOTICES